AJR ARRS Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamagami, T.
Right arrow Articles by Nishimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamagami, T.
Right arrow Articles by Nishimura, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2002; 179:1605-1610
© American Roentgen Ray Society


Embolization of the Right Gastric Artery Before Hepatic Arterial Infusion Chemotherapy to Prevent Gastric Mucosal Lesions: Approach Through the Hepatic Artery Versus the Left Gastric Artery

Takuji Yamagami1, Toshiyuki Nakamura, Shigeharu Iida, Takeharu Kato and Tsunehiko Nishimura

1 All authors: Department of Radiology, Kyoto Prefectural University of Medicine, 465 Kajii-chyo, Kawaramachi-Hirokoji, Kamigyo, Kyoto, 602-8566, Japan.

Received February 19, 2002; accepted after revision May 30, 2002.

 
Address correspondence to T. Yamagami.


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. The purpose of our study was to evaluate whether the hepatic artery or the left gastric artery is the better route of approach for selective embolization of the right gastric artery before hepatic arterial infusion chemotherapy using a port-catheter system.

SUBJECTS AND METHODS. Eighty-six patients (56 men, 30 women; mean age, 62.1 years) with unresectable advanced liver cancer underwent percutaneous implantation of a port-catheter system. In the 75 patients who had not undergone gastrectomy, right gastric artery embolization was performed before port-catheter system placement to prevent gastric mucosal lesions. In 43 patients, the approach for embolization was through a microcatheter inserted from the hepatic artery site, and in the remaining 32 patients, the approach was from the left gastric artery. The success rates of these two groups were compared.

RESULTS. Embolization was successfully accomplished at the first attempt in 72.1% of the 43 patients in whom the microcatheter was inserted from the hepatic artery site. In contrast, in 93.8% of 32 patients, embolization was successfully performed through the left gastric artery. The success rate of embolization was significantly higher in the latter group (p = 0.0173, chi-square test). A second attempt in which the catheter was redirected to another approach, performed on the same day in a majority of patients, resulted in successful embolization in an additional eight patients, with a final success rate of 92.0%.

CONCLUSION. Embolization of the right gastric artery using microcoils through a microcatheter advanced through the left gastric artery may be the preferred method for the preparation of repeated hepatic artery infusion.


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Repeated hepatic artery infusion chemotherapy through an implanted port-catheter system is accepted as therapy for patients with unresectable advanced liver malignancies [1,2,3,4]. However, paralleling the increase in such treatment has been an increase in reports describing complications after this therapy.

A frequent complication is reactive gastric or duodenal mucosal lesions caused by irritation resulting from infusion of chemotherapeutic agents into adjacent organs through arteries originating from the common hepatic artery, such as the gastroduodenal artery and the right gastric artery [5,6,7,8,9,10,11,12,13,14]. To prevent this complication, some investigators contend that it is efficacious to selectively embolize arteries supplying blood to these organs, at the time of implantation of the port-catheter system [11, 15,16,17]. However, it is our experience and that of others [11, 18, 19] that the origin of the right gastric artery, which is one of the arteries supplying adjacent organs (i.e., the stomach), is, in many cases, diminutive and angulated with anatomic variations [18, 20, 21]. Thus, it is occasionally difficult to insert a catheter selectively into the right gastric artery from the hepatic artery, and this problem results in failure to embolize the right gastric artery with coils. Through trial and error, we found a method to embolize the right gastric artery through a microcatheter advanced through the left gastric artery. The aim of our study was to evaluate whether this approach was more useful than that through the site of the hepatic artery.


Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Patients
During a 39-month period (April 1998-June 2001), 86 patients (56 men and 30 women; mean age, 62.1 years; age range, 39-83 years) with unresectable advanced liver cancer underwent percutaneously implantable port-catheter system placement with the catheter tip fixed at the gastroduodenal artery by embolic agents placed on the outside of the catheter. The catheter had a side hole that opened at the common hepatic artery to administer hepatic artery infusion chemotherapy.

Of the 86 patients, 34 had primary liver cancer, and 52 had metastatic liver cancer that originated from colorectal (n = 22), breast (n = 13), gastric (n = 8), lung (n = 3), gallbladder (n = 2), pancreatic (n = 1), ovarian (n = 1), anal (n = 1), and jejunal (n = 1) cancers. In all patients, there were diffuse or multiple (> five) malignant lesions or a few large (> 5 cm) malignant lesions in both the right and left lobes of the liver, making surgical resection impossible. Most of these patients had been administered systemic chemotherapy or other interventional treatments, only to develop intractable disease.

In 75 patients, as the first step in the port-catheter implantation procedure or on the day before port-catheter implantation, the right gastric artery was embolized to prevent infusion of chemotherapeutic agents into the stomach. Gastrectomy was performed previously in the remaining 11 patients (gastric cancer, n = 8; gastric ulcer, n = 3), and the right gastric artery had been ligated at the time of surgery. Thus, embolization was not required in these patients.

Procedures
Percutaneous placement of long-term indwelling catheters was performed for frequent arterial infusion chemotherapy, according to the procedure of Arai et al. [16] (Fig. 1), as follows: First, a 5-French catheter was inserted from a branch of the left subclavian artery or the right femoral artery, both of which were exposed by minimally invasive surgery using local anesthetic, and was advanced to the common hepatic artery through the celiac artery. Second, a microcatheter (Renegade-18; Boston Scientific, Watertown, MA) was inserted coaxially, after which the posterosuperior pancreaticoduodenal artery was embolized with microcoils (Diamond Coil, Boston Scientific; or Trufill, Cordis, Miami, FL) to prevent infusion of chemotherapeutic agents into the duodenum and pancreas. Third, using the catheter exchange method, we inserted an indwelling catheter with a side hole with the tip into the gastroduodenal artery. The side hole was placed into the common hepatic artery. Fourth, the distal lumen of the indwelling catheter was occluded with a 1.2-cm microcoil (Hilal Embolization Microcoils; Cook Europe, Bjaeverskov, Denmark) through a coaxial microcatheter advanced inside the indwelling catheter beyond the side hole. Fifth, the gastroduodenal artery was embolized with microcoils (Diamond Coil [2.3-8.0 cm long when straightened], Boston Scientific; or Trufill [2.0-6.0 cm long when straightened], Cordis) through a microcatheter inserted through the side hole of the indwelling catheter coaxially into the gastroduodenal artery outside the indwelling catheter. In many cases, 0.5-1.5 mL of n-butyl cyanoacrylate (Histoacryl-Blue; Braun, Melsungen, Germany) mixed with Lipiodol ([iodized oil] Laboratoire Guerbet, Roissy, France) was added for sufficient embolization. Finally, the proximal end of the indwelling catheter was connected to a port (Septum Port; Sumitomo Bakelite, Akita, Japan) implanted subcutaneously. A 5-French polyurethane-covered catheter with a tapered tip (Anthron P-U catheter; Toray Medical, Tokyo, Japan) was used in 80 patients as the indwelling catheter. The operator made a side hole at the region in which the diameter was tapered, using a small scissors after folding the indwelling catheter, and then cut off the redundant distal part of the catheter tip. In the remaining six patients, a Gently catheter (Solution, Tokyo, Japan) in which a side hole is created during manufacturing was used.



View larger version (21K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1. Schematic diagram of desired catheter position and occluded vessels for infusion according to Arai et al. [16]. Tip of catheter is located in gastroduodenal artery, and side hole (open arrow), through which anticancer drugs (short thin arrows) infused through port would be distributed to intrahepatic artery branches, is open toward common hepatic artery. Lumen of catheter tip is occluded with microcoil (arrowhead). Catheter tip is tightly fixed in gastroduodenal artery with microcoils (large arrow) and mixture of n-butyl cyanoacrylate and Lipiodol ([iodized oil] Laboratoire Guerbet, Roissy, France) (short solid arrow) placed on outside catheter. Right gastric artery and posterosuperior pancreaticoduodenal artery are embolized with microcoils (curved arrows). F = right gastric artery, C = left gastric artery, A = celiac artery, B = splenic artery, D = common hepatic artery, G = posterosuperior pancreaticoduodenal artery, E = gastroduodenal artery.

 

The right gastric artery was embolized in 75 patients. In the first 43 patients, the right gastric artery was embolized with microcoils (Diamond Coil [2.3 or 4.1 cm long when straightened], Boston Scientific; or Trufill [2.0 or 4.0 cm long when straightened], Cordis) through a microcatheter advanced through the common or proper hepatic artery, coaxially inserted from a 5-French catheter positioned in the celiac or common hepatic artery. Then, in the subsequent 32 patients, we performed embolization from the left gastric artery site after noticing the usefulness of such an approach. With this modification, embolization of the right gastric artery was performed through a microcatheter advanced through the left gastric artery, coaxially inserted from a 5-French catheter positioned in the celiac axis or the origin of the left gastric artery (Fig. 2A,2B,2C,2D,2E). Before embolization, celiac arteriography was performed in all 75 patients to delineate the precise anatomy.



View larger version (169K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A. 49-year-old woman with liver metastasis from breast cancer. Celiac arteriogram obtained before implantation of port-catheter system shows multiple foci of ring enhancement corresponding to liver malignancies. Note that right gastric artery (arrow) can be seen.

 


View larger version (149K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B. 49-year-old woman with liver metastasis from breast cancer. Arteriogram obtained via microcatheter (thick arrow) coaxially advanced from 5-French catheter placed in left gastric artery (short thin arrow) shows communication between left and right gastric arteries (long thin arrow).

 


View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C. 49-year-old woman with liver metastasis from breast cancer. Arteriogram obtained after microcatheter was advanced into right gastric artery shows right gastric artery arising from left hepatic artery (arrow).

 


View larger version (148K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2D. 49-year-old woman with liver metastasis from breast cancer. Common hepatic arteriogram obtained after embolization of right gastric artery through microcatheter via left gastric artery confirms completely embolized right gastric artery.

 


View larger version (195K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2E. 49-year-old woman with liver metastasis from breast cancer. Arteriogram obtained through port just after implantation of port-catheter system and 5 days after embolization of right gastric artery shows that indwelling port-catheter system is correctly implanted percutaneously. All hepatic artery branches are shown. Distal tip of catheter is fixed to gastroduodenal artery with five microcoils (long thin arrows) and n-butyl cyanoacrylate—Lipiodol ([iodized oil] Laboratoire Guerbet, Roissy, France) mixture. Distal lumen of indwelling catheter is occluded with microcoil (thick arrow). Note that right gastric artery (small thin arrow) is embolized with two microcoils.

 

These procedures were performed in the interventional radiology suite, by one of three experienced interventional radiologists, after written informed consent was obtained from the patient.

Parameters Investigated
The rates of success of the two approaches (through the common or proper hepatic artery and through the left gastric artery) of embolization of the right gastric artery were compared. The chi-square test was additionally used for statistical comparison of these two groups. Moreover, when embolization failed at the first approach, future management of the right gastric artery, thereafter, was investigated.


Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
A series of angiographic examinations revealed that among the 75 patients who had not undergone gastrectomy, the origins of the right gastric artery were the proper hepatic artery (n = 38, 50.7%), the common hepatic artery (n = 7, 9.3%), the left hepatic artery (n = 19, 25.3%), the right hepatic artery (n = 7, 9.3%), the middle hepatic artery (n = 2, 2.7%), and the gastroduodenal artery (n = 2, 2.7%). In both cases in which the right gastric artery arose from the gastroduodenal artery, the right gastric artery arose from the point near the bifurcation. To achieve complete embolization, we decided also to attempt embolization of the right gastric artery in these two patients, although the embolization of the gastroduodenal artery as performed in all patients might result in embolization of the right gastric artery as well.

Overall, in 61 (81.3%) of the 75 patients, the right gastric artery was successfully embolized at the first trial; an additional trial resulted in successful embolization in an additional eight patients, with a final success rate of 92.0% (69/75).

In 31 (72.1%) of the 43 patients in whom the microcatheter was advanced through the site of the hepatic artery, the right gastric artery was successfully catheterized at the first trial. In six of the remaining 12 patients, the right gastric artery was catheterized by changing the route for advancement of the microcatheter to the left gastric artery, and embolization was accomplished, whereas in the other six patients, attempts at embolization were abandoned because we had not yet noticed the usefulness of the approach from the left gastric artery.

On the other hand, of the 32 patients in whom the microcatheter was advanced through the left gastric artery, the right gastric artery was successfully catheterized at the first trial in 30 patients (93.8%). In one of the two patients in whom catheterization by this route was not accomplished, there was no communication between the right and left gastric arteries. In the second patient, mild intimal injury occurred while the microcatheter was advanced to the right gastric artery from the left gastric artery, thus preventing embolization by this pathway. In these two patients, embolization was achieved after changing the approach route to that from the hepatic artery site.

In summary, the success rate at the first trial to selectively advance a microcatheter into the right gastric artery was significantly higher when the approach was through the left gastric artery than through the hepatic artery (p = 0.0173, chisquare test).

The mean number of microcoils used among all patients in whom embolization was accomplished was 2.2 ± 0.8 (mean ± SD; range, 1-4). When the microcatheter was inserted through the hepatic artery, the mean number of microcoils used was 1.8 ± 0.8 (mean ± SD; range, 1-3), whereas the mean number was 2.4 ± 0.7 (mean ± SD; range, 1-4) when the microcatheter was advanced through the left gastric artery.

Gastrointestinal symptoms developed acutely after hepatic artery infusion chemotherapy in four patients who also had gastric mucosal lesions as revealed on endoscopy. Two (33.3%) were among the six patients in whom embolization of the right gastric artery could not be accomplished; embolization had been successful in the other two. In the former two patients, severe gastric ulcers occurred, necessitating abandonment of further hepatic artery infusion chemotherapy. In the latter two patients, both gastric ulcers and gastritis occurred. Arteriography performed while contrast material was infused through the port revealed recanalization of the right gastric artery in one of these patients; in the other patient, the right gastric artery was sufficiently embolized. In both patients, chemotherapy through the port-catheter system was withdrawn, and the gastric ulcers were treated. In addition, in the patient whose right gastric artery was recanalized, embolization was again performed. After an interval, intraarterial infusion chemotherapy was resumed.


Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Repeated hepatic artery infusion chemotherapy through an implanted port-catheter system is one of the last-resort treatments for patients with unresectable advanced liver cancer [1, 2]. In the past, such catheter placement was performed at surgical laparotomy using a general anesthetic [3, 4, 9, 22], making this treatment an invasive procedure. However, recent advancements in interventional techniques allow implantation of port-catheter systems percutaneously using a local anesthetic [16, 23,24,25,26,27,28,29,30,31,32].

A weak point in this system is the inability to easily and safely withdraw the indwelling catheter if either the patient or the referring physician wants the catheter to be retracted during follow-up or after successful treatment of hepatic malignant lesions. However, despite this disadvantage, among various methods to implant port-catheter systems using interventional techniques [16, 23,24,25,26, 30, 31], the fixed-catheter-tip technique as described by Arai et al. [16], which we used, is advantageous because of the low frequency of hepatic artery occlusion, which was shown to occur in only 5.3% of 115 patients [28]. Such a low rate of hepatic artery occlusion is mainly due to the lack of mechanical stimulation of the hepatic artery wall by movement of the catheter tip because the catheter is fixed in the gastroduodenal artery.

In our previous research [32], the rate of catheter dislocation with the fixed-catheter-tip technique was only 4.4% of the 45 patients. In the most common interventional procedure, in which the indwelling catheter tip is positioned in the proper or the common hepatic artery, catheter dislocation occurs at a relatively higher rate (6-18%) [23, 26, 30, 31]. Thus, the procedure we report is also useful to avoid catheter dislocation because the distal tip of the catheter is tightly fixed to the gastroduodenal artery with embolic agents such as coils and n-butyl cyanoacrylate.

Another advantage of the fixed-catheter-tip technique is the prevention of some gastroduodenal mucosal lesions and of damage to the pancreas caused by the intraarterial infusion of chemotherapeutic agents to adjacent organs supplied from the common hepatic artery, such as the duodenum and pancreas, because the gastroduodenal artery is embolized during indwelling catheter placement.

However, there remains the problem of gastromucosal lesions, which are reported to occur in 3.2-47.5% of these patients [5,6,7,8,9,10,11], caused by opening the right gastric artery, through which chemotherapeutic agents are distributed to the wall of the stomach. To avoid this drug-induced complication, researchers have strongly proposed embolization of the right gastric artery [11, 16, 17]. Inaba et al. [17] conducted a review of 217 patients who underwent repeated hepatic artery infusion chemotherapy and found that only 2.6% of 192 patients in whom the right gastric artery was sufficiently embolized before percutaneous port-catheter placement developed gastric mucosal lesions, whereas 36.0% of 25 patients without sufficient embolization developed such lesions. This difference was statistically significant. In our study, definite gastric lesions developed in only two (2.9%) of 69 patients having gastric artery embolization.

The right gastric artery is usually small (<2 mm in diameter), angulated, and rich in anatomic variations [11]. Hence, it is sometimes difficult to selectively advance catheters from the site of the hepatic artery into the right gastric artery. Regarding anatomic variations, the most commonly reported sites of divergence of the right gastric artery are the proper hepatic artery with a frequency of 40-52% [11, 20, 21] and the right or left hepatic artery with a frequency of 21-42% [11, 20, 21]. Divergence has also been reported in the common hepatic artery (1.5-10%) [20, 21] and gastroduodenal artery (1.5%) [21]. These sites correspond to sites from which the right gastric artery diverged in subjects of our study; this correspondence suggests that our subjects did not differ appreciably from those of other cohorts.

The right gastric artery generally anastomoses with the left gastric artery [19]. This fact led us to speculate that advancing the microcatheter to the right gastric artery through the left gastric artery would be possible, even though the hepatic artery was usually used for this purpose. In our study, the rate of successful embolization at the first trial was significantly higher in patients in whom the microcatheter was advanced through the left gastric artery instead of through the hepatic artery. In addition, in six (50%) of 12 patients in whom embolization of the right gastric artery through the hepatic artery site failed, a change in approach to the left gastric artery resulted in success.

Our technique (i.e., advancing the microcatheter through the left gastric artery to the right gastric artery) might be useful in other scenarios as well. Embolization of the right gastric artery using this approach might be applied in patients who have undergone port-catheter placement at surgical laparotomy with failure of right gastric artery ligation or in patients undergoing episodic hepatic artery infusion chemotherapy. This technique might be used to protect the right gastric artery from any agents used for hepatic artery embolization. Our new approach might also serve as a more direct collateral pathway, allowing transcatheter hepatic artery chemoembolization of the hepatic artery for liver malignancies in patients with common or proper hepatic artery stenosis or occlusion. These patients otherwise might undergo chemoembolization from the superior mesenteric artery through pancreaticoduodenal pathways.

The results of our study show that advancement of microcatheters through the left gastric artery into the right gastric artery is a useful method for the preparation of long-term hepatic artery infusion chemotherapy. This route may also be used as an alternative approach when the usual route via the site of the hepatic artery fails. The limitation of using this route is that the anastomosis between the right and left gastric artery may be too small to advance the microcatheter or may not exist.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000;18:243 -254[Abstract/Free Full Text]
  2. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasis. Lancet 1994;344:1255 -1260[Medline]
  3. Valeri A, Mini E, Tonelli P, et al. Intra-arterial hepatic chemotherapy with 5-Fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer. Anticancer Res 1994;14:2215 -2219[Medline]
  4. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112 -1118[Abstract]
  5. Fiorentini G, Poddie DB, Giorgi UD, et al. Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol 2000;17:163 -173[Medline]
  6. Doria MI, Doria LK, Faintuch J, Levin B. Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine: a clinical and pathologic study. Cancer 1993;74:2042 -2047
  7. Shike M, Gillin JS, Kemeny N, Daly JM, Kurtz RC. Severe gastroduodenal ulcerations complicating hepatic artery infusion chemotherapy for metastatic colon cancer. Am J Gastroenterol 1986;81:176 -179[Medline]
  8. Narsete T, Ansfield F, Wirtanen G, Ramirez G, Wolberg W, Jarrett F. Gastric ulceration in patients receiving intrahepatic infusion 5-fluorouracil. Ann Surg 1977;186:734 -736[Medline]
  9. Niederhuber JE, Ensminger WD. Surgical considerations in the management of hepatic neoplasia. Semin Oncol 1983;10:135 -147[Medline]
  10. Cady B. Hepatic arterial patency and complications after catheterization for infusion chemotherapy. Ann Surg 1973;178:156 -161[Medline]
  11. Chuang VP, Wallace S, Stroehlein J, Yap HY, Patt YZ. Hepatic artery infusion chemotherapy: gastroduodenal complications. AJR 1981;137:347 -350[Abstract/Free Full Text]
  12. Jewell LD, Fields AL, Murray CJW, Thomson ABR. Erosive gastroduodenitis with marked epithelial atypia after hepatic arterial infusion chemotherapy. Am J Gastroenterol 1985;80:421 -424[Medline]
  13. Wells JJ, Nostrant TT, Wilson JAP, Gyves JW. Gastroduodenal ulcerations in patients receiving selective hepatic artery infusion chemotherapy. Am J Gastroenterol 1985;80:425 -429[Medline]
  14. Kwee WS, Wils JA, Schlangen J, Nuyens CM, Arends JW. Gastric epithelial atypia complicating hepatic arterial infusion chemotherapy. Histopathology 1994;24:151 -154[Medline]
  15. Granmayeh M, Wallace S, Schwarten D. Transcatheter occlusion of the gastroduodenal artery. Radiology 1979;131:59 -64[Abstract]
  16. Arai Y, Inaba Y, Takeuchi Y. Interventional techniques for hepatic arterial infusion chemotherapy. In: Castaneda-Zuniga WR, ed. Interventional radiology, 3rd ed. Baltimore: Williams & Wilkins, 1997:192 -205
  17. Inaba Y, Arai Y, Matsueda K, Takeuchi Y, Aramaki T. Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 2001;12:957 -963[Medline]
  18. Michels NA. Blood supply and anatomy of the upper abdominal organs. Philadelphia: Lippincott, 1955
  19. Reuter SR, Redman HC, Cho KJ. Gastrointestinal angiography, 3rd ed. New York: Saunders, 1986: 32-77
  20. Luzca G. X-ray anatomy of the vascular system. Budapest: Butterworth, 1974:224 -293
  21. Hiramatsu K, Kouda E, Mouri M, Isobe Y. X-ray anatomy of the abdominal vascular system. Tokyo: Igaku-Shoin, 1982: 123-124
  22. Huk I, Entsheff P, Prager M, Schulz F, Polterauer P, Funovics J. Patency rate of implantable devices during long-term intraarterial chemotherapy. Angiology 1990;41:936 -941
  23. Wacker FK, Boese-Landgraf J, Wagner A, Albrecht D, Wolf K-J, Fobbe F. Minimally invasive catheter implantation for regional chemotherapy of the liver: a new percutaneous transsubclavian approach. Cardiovasc Intervent Radiol 1997;20:128 -132[Medline]
  24. Clouse ME, Ahmed R, Ryan RB, Oberfield RA, McCaffrey JA. Complications of long term transbrachial hepatic arterial infusion chemotherapy. AJR 1977;129:799 -803[Abstract]
  25. Oberfield RA, McCaffrey JA, Polio J, Clouse ME, Hamilton T. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 1979;44:414 -423[Medline]
  26. Herrmann KA, Waggershauser T, Sittek H, Reiser MF. Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology 2000;215:294 -299[Abstract/Free Full Text]
  27. Seki H, Kimura M, Yoshimura N, Yamamoto S, Ozaki T, Sakai K. Hepatic arterial infusion chemotherapy using percutaneous catheter placement with an implantable port: assessment of factors affecting patency of the hepatic artery. Clin Radiology 1999; 54:221 -227[Medline]
  28. Takeuchi Y, Arai Y, Inaba Y, et al. A new percutaneous catheterization "side-holed catheter placement with fixation" for a long term arterial chemotherapeutic infusion: its effectiveness to prevent hepatic arterial occlusion. J Jpn Soc Angiography Interv Radiol 1996;11:471 -476
  29. Shindoh N, Ozaki Y, Kyogoku S, Yamana D, Sumi Y, Katayama H. Stabilization of a percutaneously implanted port catheter system for hepatic artery chemotherapy infusion. Cardiovasc Intervent Radiol 1999;22:344 -347[Medline]
  30. Germer CT, Boese-Landgraf J, Albrecht D, Wagner A, Wolf KJ, Buhr HJ. The totally implantable minimally invasive hepatic arterial catheter for intraarterial chemotherapy of unresectable liver metastasis in cases of dysfunction of arterial access devices. Chirurg 1996;67:458 -462[Medline]
  31. Strecker E-PK, Boos IBL, Ostheim-Dzerowycz W, Heber R, Vetter SC. Percutaneously implantable catheter-port system: preliminary technical results. Radiology 1997;202:574 -577[Abstract/Free Full Text]
  32. Yamagami T, Nakamura T, Yamazaki S, Iida S, Kato T, Nishimura T. Catheter-tip fixation of a percutaneously implanted port-catheter system to prevent dislocation. Eur Radiol 2002;12:443 -449[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
A. Ganeshan, S. Upponi, L.-q. Hon, D. Warakaulle, and R. Uberoi
Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology
Ann. Onc., May 1, 2008; 19(5): 847 - 851.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Yamagami, T. Kato, S. Iida, T. Hirota, and T. Nishimura
Management of End Hole in Placement of Port-Catheter System for Continuous Hepatic Arterial Infusion Chemotherapy Using the Fixed Catheter Tip Method
Am. J. Roentgenol., April 1, 2005; 184(4): 1332 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Yamagami, T. Kato, S. Iida, T. Hirota, and T. Nishimura
Efficacy of the Left Gastric Artery as a Route for Catheterization of the Right Gastric Artery
Am. J. Roentgenol., January 1, 2005; 184(1): 220 - 224.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. Yamagami, T. Kato, S. Iida, O. Tanaka, and T. Nishimura
Value of Transcatheter Arterial Embolization with Coils and n-Butyl Cyanoacrylate for Long-term Hepatic Arterial Infusion Chemotherapy
Radiology, March 1, 2004; 230(3): 792 - 802.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamagami, T.
Right arrow Articles by Nishimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamagami, T.
Right arrow Articles by Nishimura, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS